CPT1A and malignant colon neoplasm: CPT1A upregulation is a key metabolic alteration that cancer cells use to promote β-catenin acetylation and activation, while knockdown of CPT1A can reduce the expression of genes linked with colon cancer cells downstream of Wnt/β-catenin (Wen et al., 2017).